Clinical Trials / Research Studies
Immune Deficiency and Histiocytosis

Common Variable Immunodeficiency With Interstitial Lung Disease Study for Children and Adults

  • Gender: Female, Male

Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to test the drug abatacept to see what effects is has on interstitial lung disease in patients with common variable immunodeficiency, looking at its impact, safety and tolerability. ...More

Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for HLH: The HIT-HLH trial

  • Gender: Female, Male

Cincinnati Children's is conducting a research study to evaluate the safety and effectiveness of a treatment regimen combining two previous approaches to treat patients with HLH. ...More

NI-0501: A Study to Investigate the Safety and Efficacy of an Anti-IFNγ mAb in Children Affected by Primary Hemophagocytic Lymphohistiocytosis

  • Gender: Female, Male

Cincinnati Children's is participating in a research study sponsored by NovImmune S.A. to evaluate the safety, tolerability and preliminary efficacy of a new drug (NI-0501) aimed at controlling disease activity in patients diagnosed with primary hemophagocytic lymphohistiocytosis who show an unsatis ...More

Contact Us


Adult Participants or Parents of Participants:

Cincinnati Children’s is involved in research because it is very important to understanding diseases and developing ways to prevent and treat health problems in children, as well as adults. Learn more about how you can help. Contact us at or 513-636-0098. Or, enroll in our database to be notified about future studies by completing an online sign up form.

Sponsors and Investigators:

The Office for Clinical and Translational Research at Cincinnati Children’s provides sponsors and investigators with comprehensive support services, research tools, personnel and facilities to conduct or facilitate pediatric and adult clinical research studies. Contact us at or 513-636-0314.